Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | DBV Technologies S A | — | 5,213,361.0 | $108.9M | 8.41% | +4.2M | +423.0% | $20.89 | — |
| 2 | XENE | Xenon Pharmaceuticals Inc | Healthcare | 588,706.0 | $34.2M | 2.64% | +103K | +21.2% | $58.15 | -6.0% |
| 3 | EVMN | Evommune Inc | Healthcare | 1,455,863.0 | $33.5M | 2.58% | +1.3M | +1188.1% | $22.99 | +2.4% |
| 4 | RLAY | Relay Therapeutics Inc. | Healthcare | 2,359,586.0 | $23.5M | 1.81% | +127K | +5.7% | $9.95 | +30.9% |
| 5 | ARQT | Arcutis Biotherapeutics Inc | Healthcare | 733,966.0 | $17.3M | 1.33% | +203K | +38.2% | $23.56 | -10.8% |
| 6 | ABVX | Abivax SA | Healthcare | 107,268.0 | $11.9M | 0.92% | +51K | +90.5% | $111.35 | +11.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%